ArticleJBMR plus2024

Intermittent dosing of zoledronic acid based on bone turnover marker assessment reduces vertebral and non-vertebral fractures.

Tove Tveitan Borgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.